Epidemiological and therapeutic profile of patients with cryptococosis in the school hospital of Santa Maria/RS
DOI:
https://doi.org/10.5902/2236583432507Keywords:
Cryptococcus spp., Fungal diseases, Diagnosis, EpidemiologyAbstract
Cryptococcosis is a fungal disease caused by yeasts of the complex Cryptococcus neoformans and Cryptococcus gattii. The infection usually occurs by inhaling the basidiospores of the fungus present in the environment. Severe cases occur due to infection of the central nervous system. The disease has a worldwide distribution, mainly associated to the immunocompromised individuals with human immunodeficiency virus (HIV). This study aimed to verify the epidemiological profile and therapeutic protocols of patients diagnosed with cryptococcosis at the Hospital Universitário de Santa Maria (Santa Maria, RS), from March 2010 to March 2017. A total of 46 clinical records were evaluated, the profile of the patients was predominantly Caucasian, aged between 31 and 50 years, with HIV, presenting a CD4 + cell count <100 cells / μL and with a prevalent clinical form neurocryptococcosis. The combination of amphotericin B and fluconazole was the therapeutic protocol adopted in the majority of patients studied.Downloads
References
- Li SS, Mody CH. Cryptococcus. American Thoracic Society, v. 7, n. 3, p. 186–196, 2010.
- Queiroz JPAF, Sousa FDN, Lage RA, Izael M A, Santos A G. Criptococose -uma revisão bibliográfica. Acta Veterinaria Brasilica, v. 2, n. 2, p. 32–38, 2008.
- Fang W, Fa Z, Liao W. Epidemiology of Cryptococcus and cryptococcosis in China. Fungal Genetics and Biology, v. 78, p. 7–15, 2015.
- Vitale RG, Pascuccelli V, Afeltra J. Influence of capsule size on the in vitro activity of antifungal agents against clinical Cryptococcus neoformans var. grubii strains. Journal of Medical Microbiology, v. 61, n. 3, p. 384–388, 2012.
- Barnett JA. A history of research on yeasts 14:1 medical yeasts part 2, Cryptococcus neoformans. School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, UK, v. 27, p. 875–904, 2010.
- Pappalardo MCSM, Melhem MSC. Cryptococcosis: a review of the brazilian experience for the disease. Revista do Instituto de Medicina Tropical de São Paulo, v. 45, n. 6, p. 299–305, dez. 2003.
- Leal A. Diferenciação das espécies Cryptococcus neoformans e Cryptococcus gattiiutilizando a metodologia de PCR multiplex e determinação do perfil epidemiológico de pacientes com meningite criptocócica. Rio Grande do Sul: Universidade Federal do Rio Grande do Sul, 2006.
- Mezzari A, Wliebbelling AMP, Freitas GSO, May GG, Albé GC, Filik H P, Portich JP, et al. Criptococose em um Hospital Público de Porto Alegre: dados epidemiológicos. Journal of Infection Control, v. 2, n. 3, p. 135–139, 2013.
- Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus infected persons. European Journal of Clinical Microbiology & Infectious Diseases, v. 179, p. 449-454, 1999.
- Dromer F, Mathoulin-Pelissier S, Fontanet A, Ronin O, Dupont, B, Lortholary O. Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras AIDS. v. 18, n. 3, p. 555-562, 2004.
- Jenney A, Pandithage K, Fisher DA, Currie BJ. Cryptococcus infection in tropical Australia. Journal of Clinical Microbiology, v. 42, n. 8, p. 3865-3868, 2004.
- Consenso em criptococose. Revista da Sociedade Brasileira de Medicina Tropical, v. 41, n. 5, p. 524–544, 2008.
- Meyer W, Castaneda A, Jackson S, HuynhM, Castaneda E. Molecular typing of Ibero American Cryptococcus neoformans isolates. Emerging Infectious Diseases, v. 9, n. 2, p. 189-195, feb 2003.
- Leonhardt JM, Heymann WR. Cutaneous manifestations of other endocrine diseases. In: Freedberg, I. M., Elsen A. Z., Wolff, K., Austen, K. F., Goldsmith, L. A., Katz, S. I. Fitzpatrick's dermatology in general medici¬ne. New York: MacGraw Hill, p. 1662-1670, 2003.
- Falci D, Sprinz E. Inibidores de protease:uma revisão sobre a possibilidade de uma dose única diária. Atividade Cientifica, v. 1, n. 4, p. 14-18, 2005.
- Mora DJ, Colombo ERC, Paim KF, Silva LEA, Nascentes G A, Vergara M L S. Clinical, epidemiological and outcome features of patients with cryptococcosis in Uberaba, Minas Gerais, Brazil. Mycopathologia, v. 173, n. 5-6, p. 321-7, jun. 2012.
- Backes P, Santos JID, Borsatto EM, Reis M. Diagnóstico laboratorial de Cryptococcus sp. no líquor. Suplemento especial de microbiologia, v. 48, n. 3, p. 10–14, 2016.
- Rohatgi S, Pirofski L. Host immunity to Cryptococcus neoformans. Future Microbiology, v. 10, n. 4, p. 565–581, 2015.
- Sáez D, Bahamondes L, Lam G, Arellano L, Lillo P. Síndrome de restauración inmune asociado a tratamiento antirretroviral y criptococosis meníngea. Caso clínico. Revista Médica de Chile, v. 134, p. 10, 2006.
- Secretaria de Estado da saúde do Rio Grande do Sul. Departamento de ações em saúde. Coordenação estadual de dst/aids do Rio Grande do Sul. Boletim Epidemiologico HIV/AIDS 2016, 2017.
- Feeney C, Bryzman S, Kong L, Brazil H, Deutsch R, Fritz LC. T-lymphocyte subsets in acute illness. Critical Care Medicine, v. 23, n.10, p. 1680-1685, 1995.
- Nguyen MH, Husain S, Clancy CJ, Peacock JE, Hung CC, et al. Outcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study. Journal of Infection Control, v. 61, p. 419-426, 2010;
- Antachopoulos C, Walsh TJ. Immunotherapy of Cryptococcus infections. Clinical Microbiology and Infection, v. 18, n. 2, p. 126–133, 2012.
- Nucci M, Perfect, JR. When Primary Antifungal Therapy Fails. Clinical Infectious Diseases, v. 46, n. 9, p. 1426–1433, 2008.
- Pasa CR. Tipagem molecular e suscetibilidade antifúngica de Cryptococcus isolados de pacientes em hospital universitário com investigação domiciliar. Dissertação de mestrado - Programa de Pós-Graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Universidade Federal de Mato Grosso do Sul, p. 1–121, 2011.
- Huston SM, Mody CH. Cryptococcosis: an emerging respiratory myco¬sis.Clinics In Chest Medicine. v. 30, n. 2, p. 253-264, 2009.
